Hoh R - Search Results

1

Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2.

Yin K, Peluso MJ, Luo X, Thomas R, Shin MG, Neidleman J, Andrew A, Young K, Ma T, Hoh R, Anglin K, Huang B, Argueta U, Lopez M, Valdivieso D, Asare K, Deveau TM, Munter SE, Ibrahim R, Ständker L, Lu S, Goldberg SA, Lee SA, Lynch KL, Kelly JD, Martin JN, Münch J, Deeks SG, Henrich TJ, Roan NR. Yin K, et al. Among authors: hoh r. bioRxiv [Preprint]. 2023 Aug 4:2023.02.09.527892. doi: 10.1101/2023.02.09.527892. bioRxiv. 2023. Update in: Nat Immunol. 2024 Feb;25(2):218-225. doi: 10.1038/s41590-023-01724-6 PMID: 36798286 Free PMC article. Updated. Preprint.

2

Protease inhibitor-resistant HIV-1 from patients with preserved CD4 cell counts is cytopathic in activated CD4 T lymphocytes.

Liegler TJ, Hayden MS, Lee KH, Hoh R, Deeks SG, Granta RM. Liegler TJ, et al. Among authors: hoh r. AIDS. 2001 Jan 26;15(2):179-84. doi: 10.1097/00002030-200101260-00006. AIDS. 2001. PMID: 11216925

3

Cerebrospinal fluid response to structured treatment interruption after virological failure.

Price RW, Paxinos EE, Grant RM, Drews B, Nilsson A, Hoh R, Hellmann NS, Petropoulos CJ, Deeks SG. Price RW, et al. Among authors: hoh r. AIDS. 2001 Jul 6;15(10):1251-9. doi: 10.1097/00002030-200107060-00006. AIDS. 2001. PMID: 11426069

4

Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease gene.

Karlsson AC, Deeks SG, Barbour JD, Heiken BD, Younger SR, Hoh R, Lane M, Sällberg M, Ortiz GM, Demarest JF, Liegler T, Grant RM, Martin JN, Nixon DF. Karlsson AC, et al. Among authors: hoh r. J Virol. 2003 Jun;77(12):6743-52. doi: 10.1128/jvi.77.12.6743-6752.2003. J Virol. 2003. PMID: 12767994 Free PMC article.

5

Central memory CD4+ T cell responses in chronic HIV infection are not restored by antiretroviral therapy.

Elrefaei M, McElroy MD, Preas CP, Hoh R, Deeks S, Martin J, Cao H. Elrefaei M, et al. Among authors: hoh r. J Immunol. 2004 Aug 1;173(3):2184-9. doi: 10.4049/jimmunol.173.3.2184. J Immunol. 2004. PMID: 15265956

6

Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection.

Deeks SG, Hoh R, Neilands TB, Liegler T, Aweeka F, Petropoulos CJ, Grant RM, Martin JN. Deeks SG, et al. Among authors: hoh r. J Infect Dis. 2005 Nov 1;192(9):1537-44. doi: 10.1086/496892. Epub 2005 Sep 20. J Infect Dis. 2005. PMID: 16206068 Clinical Trial.

7

Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment.

Emu B, Sinclair E, Favre D, Moretto WJ, Hsue P, Hoh R, Martin JN, Nixon DF, McCune JM, Deeks SG. Emu B, et al. Among authors: hoh r. J Virol. 2005 Nov;79(22):14169-78. doi: 10.1128/JVI.79.22.14169-14178.2005. J Virol. 2005. PMID: 16254352 Free PMC article.

8

The independent effect of drug resistance on T cell activation in HIV infection.

Hunt PW, Deeks SG, Bangsberg DR, Moss A, Sinclair E, Liegler T, Bates M, Tsao G, Lampiris H, Hoh R, Martin JN. Hunt PW, et al. Among authors: hoh r. AIDS. 2006 Mar 21;20(5):691-9. doi: 10.1097/01.aids.0000216369.30948.18. AIDS. 2006. PMID: 16514299

9

Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses.

Deeks SG, Schweighardt B, Wrin T, Galovich J, Hoh R, Sinclair E, Hunt P, McCune JM, Martin JN, Petropoulos CJ, Hecht FM. Deeks SG, et al. Among authors: hoh r. J Virol. 2006 Jun;80(12):6155-64. doi: 10.1128/JVI.00093-06. J Virol. 2006. PMID: 16731954 Free PMC article.

10

A randomized pilot study comparing combination therapy plus enfuvirtide versus a treatment interruption followed by combination therapy plus enfuvirtide.

Beatty G, Hunt P, Smith A, Hoh R, Huang W, Martin J, Deeks SG. Beatty G, et al. Among authors: hoh r. Antivir Ther. 2006;11(3):315-9. Antivir Ther. 2006. PMID: 16759047 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters